Boston Scientific has told investors it is unlikely to meet its 2026 sales and profit forecasts after a cyberattack disrupted operations, with the company now assessing the financial damage from the breach.
Boston Scientific warns cyberattack will hit 2026 sales and profit
Boston Scientific has told investors it is unlikely to meet its 2026 sales and profit forecasts after a cyberattack disrupted operations, with the company now assessing the financial damage from the breach.
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.